Sp1047

AGA GUIDELINE Q&A: BIOMARKERS FOR MONITORING INFLAMMATION IN IBD

Date
May 9, 2023
Explore related products in the following collection:

Society: AGA

AGA guidelines are among the most rigorously evidence-based and trusted guidelines in the field of GI and hepatology. This session will give DDW attendees the rare opportunity to hear about newly published and upcoming AGA guidelines from the authors of the guideline themselves, including a Question and Answer portion. It also provides an additional public forum to have the guidelines heard and discussed, in addition to our 30-day public comment period, contributing to an open and transparent process of guideline development.

Presenters

Speaker Image for Ashwin Ananthakrishnan
Massachusetts General Hospital

Tracks

Related Products

Thumbnail for ANTI-TNF IN COMBINATION WITH LOW DOSE METHOTREXATE OUTPERFORMS ANTI-TNF MONOTHERAPY IN PATIENTS WITH PEDIATRIC CROHN'S DISEASE INITIATING ADALIMUMAB BUT NOT INFLIXIMAB
ANTI-TNF IN COMBINATION WITH LOW DOSE METHOTREXATE OUTPERFORMS ANTI-TNF MONOTHERAPY IN PATIENTS WITH PEDIATRIC CROHN'S DISEASE INITIATING ADALIMUMAB BUT NOT INFLIXIMAB
BACKGROUND: Tumor necrosis factor inhibitors (TNFi) are a mainstay of pediatric Crohn’s disease (PCD) therapy; yet not all patients respond, and others lose response over time. Combination therapy with methotrexate may improve response; however, this has not been rigorously evaluated…
Thumbnail for PANEL DISCUSSION
PANEL DISCUSSION
In the last five years, there have been three distinct small molecules that have been approved for the management of ulcerative colitis…
Thumbnail for EMPIRIC DIETARY INFLAMMATORY PATTERN (EDIP) IS INVERSELY ASSOCIATED WITH RISK OF MICROSCOPIC COLITIS
EMPIRIC DIETARY INFLAMMATORY PATTERN (EDIP) IS INVERSELY ASSOCIATED WITH RISK OF MICROSCOPIC COLITIS
BACKGROUND The gut microbiome is central to Crohn’s disease (CD) pathogenesis but the relative contribution of different environmental factors to disease compositional variation is unknown…